Neuropathic Pain and Fabry Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Fabry disease is a rare X-linked lysosomal storage disorder. The mutations result in a deficiency of the lysosomal enzyme α-galactosidase causing accumulation of glycosphingolipids in the vascular endothelial cells and many other tissues. An early sign of the disease is painful small fibre neuropathy presenting in two forms: 1. a constant burning sensation in the hand and feet and 2. Fabry crises consisting of attacks of excruciating pain. Given the X-linked inheritance, male patients are severely affected. Recently attention has been drawn to female patients whether they also show signs of nerve involvement.
The purpose of this study is to evaluate the small fibre neuropathy in female Fabry patients. Correlation with X-chromosome inactivation will be attempted. Recombinant human α-galactosidase A is now available for patients. A part of this study is evaluation the long term efficacy of enzyme replacement therapy in female patients with Fabry disease and neuropathy.
Male family members with Fabry disease will be examined.
| Condition |
|---|
|
Fabry Disease |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Somatosensoric and Autonomic Disturbances in Female Patients With Fabry Disease |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- All adult patients with confirmed Fabry disease
Exclusion Criteria:
- Patients who cannot cooperate
- Patients who are unable to understand the purpose
Contacts and Locations| Denmark | |
| Danish Pain Research Center, Aarhus University Hospital | |
| Aarhus, Denmark, 8000 | |
| Principal Investigator: | Anette T Moller, MD | Danish Pain Research Center |
| Study Chair: | Troels S Jensen, MD, PhD | Danish Pain Research Center |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00168974 History of Changes |
| Other Study ID Numbers: | Fabry2003 |
| Study First Received: | September 13, 2005 |
| Last Updated: | November 15, 2007 |
| Health Authority: | Denmark: National Board of Health |
Additional relevant MeSH terms:
|
Fabry Disease Sphingolipidoses Lysosomal Storage Diseases, Nervous System Brain Diseases, Metabolic, Inborn Brain Diseases, Metabolic Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Genetic Diseases, X-Linked Genetic Diseases, Inborn Metabolism, Inborn Errors Lipidoses Lipid Metabolism, Inborn Errors Lysosomal Storage Diseases Metabolic Diseases Lipid Metabolism Disorders |
ClinicalTrials.gov processed this record on June 13, 2013